IBM gives cancer-killing drug AI project to the open source community ZDNet

IBM has released three artificial intelligence (AI) projects tailored to take on the challenge of curing cancer to the open-source community. At the 18th European Conference on Computational Biology (ECCB) and the 27th Conference on Intelligent Systems for Molecular Biology (ISMB), which will be held in Switzerland later this month, the tech giant will dive into how each of the projects can advance our understanding of cancers and their treatment. Cancer alone is estimated to have caused 9.6 million deaths in 2018, with an estimated 18 million new cases reported in the same year. Predisposition through genetics, environmental factors including pollution, smoking, and diet are all considered factors in how likely someone is to develop such a disease, and while we can treat many forms, we still have much to learn. Researchers from IBM's Computational Systems Biology group in Zurich are working on AI and machine learning (ML) approaches to "help to accelerate our understanding of the leading drivers and molecular mechanisms of these complex diseases," as well as methods to improve our knowledge of tumor composition.